Temat: "Febrile neutropenia" - OpacWWW

Skocz do pozycji: 1 1.

Tytuł :: Plasma Microbial Cell-free DNA Next-generation Sequencing in the Diagnosis and Management of Febrile Neutropenia.
Autorzy :: Benamu E; School of Medicine, Division of Infectious Diseases, University of Colorado Denver, Aurora, Colorado, USA.
Gajurel K; Division of Infectious Diseases, Carolinas Medical Center, Atrium Health, Charlotte, North Carolina, USA.
Anderson JN; Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.
Lieb T; Hematopoietic Malignancies Unit Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California, USA.
Gomez CA; Division of Infectious Diseases, Department of Medicine, University of Utah, Salt Lake City, Utah, USA.
Seng H; Cytovale, Inc., San Francisco, California, USA.
Aquino R; Karius, Inc., Redwood City, California, USA.
Hollemon D; Karius, Inc., Redwood City, California, USA.
Hong DK; Vir Biotechnology Inc., San Francisco, California, USA.
Blauwkamp TA; Karius, Inc., Redwood City, California, USA.
Kertesz M; Karius, Inc., Redwood City, California, USA.
Blair L; Karius, Inc., Redwood City, California, USA.
Bollyky PL; Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.
Medeiros BC; Division of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.
Coutre S; Division of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.
Zompi S; Sangamo Therapeutics Inc, Brisbane, California, USA.
Montoya JG; The Dr. Jack S. Remington Laboratory for Specialty Diagnostics at the Palo Alto Medical Foundation, Palo Alto, California, USA.
Deresinski S; Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.; Pokaż więcej
Źródło :: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2022 May 03; Vol. 74 (9), pp. 1659-1668.
Typ publikacji :: Journal Article
MeSH Terms :: Cell-Free Nucleic Acids*
Febrile Neutropenia*/diagnosis
Febrile Neutropenia*/drug therapy
Febrile Neutropenia*/etiology
Anti-Bacterial Agents/therapeutic use ; Fever/etiology ; High-Throughput Nucleotide Sequencing ; Humans ; Prospective Studies
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 2 2.

Tytuł :: Association of mannose-binding lectin 2 (MBL2) and suppressor of cytokine signaling-1 (SOCS1) gene variants in children with febrile neutropenia.
Autorzy :: Uysalol EP; Basaksehir Cam and Sakura City Hospital, Department of Pediatric Hematology- Oncology, Turkey.
Uysalol M; Istanbul University, Istanbul Faculty of Medicine, Department of Pediatrics, Division of Pediatric Emergency, Turkey.
Pehlivan M; Gaziantep University, Faculty of Medicine, Department of Hematology, Turkey.
Oyaci Y; Istanbul University, Istanbul Faculty of Medicine, Department of Medical Biology and Genetics, Turkey.
Pehlivan S; Istanbul University, Istanbul Faculty of Medicine, Department of Medical Biology and Genetics, Turkey.
Serin I; University of Health Science, Istanbul Training and Research Hospital, Department of Department of Hematology, Turkey. Electronic address: .; Pokaż więcej
Źródło :: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2022 May; Vol. 28 (5), pp. 657-662. Date of Electronic Publication: 2022 Feb 01.
Typ publikacji :: Journal Article
MeSH Terms :: Febrile Neutropenia*/etiology
Febrile Neutropenia*/genetics
Mannose-Binding Lectin*/genetics
Neoplasms*/complications
Suppressor of Cytokine Signaling 1 Protein*/genetics
Case-Control Studies ; Child ; Genetic Predisposition to Disease ; Genotype ; Humans
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 3 3.

Tytuł :: Difference of compliance rates for the recommendations in Japanese Guideline on Febrile Neutropenia according to respondents' attributes: the second report on a questionnaire survey among hematology-oncology physicians and surgeons.
Autorzy :: Akiyama N; Department of Internal Medicine, School of Medicine, Teikyo University, Kaga 2-11-1, Itabashi ward, Tokyo, 173-8605, Japan. .
Okamura T; Department of Breast Surgery, School of Medicine, Tokai University, Isehara, Kanagawa, Japan.
Yoshida M; Fourth Department of Internal Medicine, Teikyo University Hospital Mizonokuchi, Kawasaki, Kanagawa, Japan.
Kimura SI; Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Saitama, Japan.
Yano S; Division of Clinical Oncology and Hematology, The Jikei University School of Medicine, Minato, Tokyo, Japan.
Yoshida I; Department of Hematologic Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Ehime, Japan.
Kusaba H; Department of Comprehensive Clinical Oncology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Fukuoka, Japan.
Takahashi K; Department of Respiratory Medicine, Anjo Kosei Hospital, Anjo, Aichi, Japan.
Fujita H; Department of Hematology, Saiseikai Yokohama Nanbu Hospital, Yokohama, Kanagawa, Japan.
Fukushima K; Department of Pediatrics, Dokkyo Medical University, Mibu, Tochigi, Japan.
Iwasaki H; Department of Infection Control and Prevention, Faculty of Medical Sciences, University of Fukui, Eiheiji, Fukui, Japan.
Tamura K; Professor Emeritus, Fukuoka University, Fukuoka, Fukuoka, Japan.
Saeki T; Department of Breast Oncology, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan.
Takamatsu Y; Department of Hematology, Oncology, Endocrinology and Infectious Disease, Fukuoka University, Fukuoka, Fukuoka, Japan.
Zenda S; Department of Radiation Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan.; Pokaż więcej
Źródło :: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2022 May; Vol. 30 (5), pp. 4327-4336. Date of Electronic Publication: 2022 Jan 29.
Typ publikacji :: Journal Article
MeSH Terms :: Febrile Neutropenia*/chemically induced
Febrile Neutropenia*/drug therapy
Febrile Neutropenia*/prevention & control
Hematology*
Neoplasms*/drug therapy
Surgeons*
Female ; Granulocyte Colony-Stimulating Factor/therapeutic use ; Humans ; Japan ; Male ; Medical Oncology ; Surveys and Questionnaires
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 4 4.

Tytuł :: Retrospective Cohort Study of Clinical Efficacy and Safety of Cefozopran for Treating Febrile Neutropenia during Chemotherapy in Patients with Lung Cancer.
Autorzy :: Higashionna T; Department of Pharmacy, Okayama University Hospital.
Ushio S; Department of Pharmacy, Okayama University Hospital.
Esumi S; Department of Pharmacy, Okayama University Hospital.
Murakawa K; Department of Pharmacy, Okayama University Hospital.
Kitamura Y; Department of Pharmacy, Okayama University Hospital.; Department of Pharmacotherapy, School of Pharmacy, Shujitsu University.
Sendo T; Department of Pharmacy, Okayama University Hospital.; Pokaż więcej
Źródło :: Acta medica Okayama [Acta Med Okayama] 2022 Apr; Vol. 76 (2), pp. 167-172.
Typ publikacji :: Journal Article
MeSH Terms :: Febrile Neutropenia*/chemically induced
Febrile Neutropenia*/drug therapy
Lung Neoplasms*/drug therapy
Anti-Bacterial Agents/adverse effects ; Cefepime/adverse effects ; Cephalosporins/adverse effects ; Humans ; Retrospective Studies ; Treatment Outcome
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 5 5.

Tytuł :: Febrile neutropenia management and outcomes in hematopoietic cell transplantation for chronic granulomatous disease.
Autorzy :: Parta M; Clinical Research Directorate, Frederick National Laboratory for Cancer Research, Bethesda, Maryland, USA.
Cuellar-Rodriguez J; National Institute of Allergy and Infectious Diseases/National Institutes of Health, Bethesda, Maryland, USA.
Gea-Banacloche J; National Institute of Allergy and Infectious Diseases/National Institutes of Health, Bethesda, Maryland, USA.
Qin J; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases/National Institutes of Health, Bethesda, Maryland, USA.
Kelly C; National Institute of Allergy and Infectious Diseases/National Institutes of Health, Bethesda, Maryland, USA.
Zerbe CS; National Institute of Allergy and Infectious Diseases/National Institutes of Health, Bethesda, Maryland, USA.
Holland SM; National Institute of Allergy and Infectious Diseases/National Institutes of Health, Bethesda, Maryland, USA.
Malech HL; National Institute of Allergy and Infectious Diseases/National Institutes of Health, Bethesda, Maryland, USA.
Kang EM; National Institute of Allergy and Infectious Diseases/National Institutes of Health, Bethesda, Maryland, USA.; Pokaż więcej
Źródło :: Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2022 Apr; Vol. 24 (2), pp. e13815. Date of Electronic Publication: 2022 Mar 10.
Typ publikacji :: Journal Article
MeSH Terms :: Febrile Neutropenia*/drug therapy
Febrile Neutropenia*/etiology
Gram-Negative Bacterial Infections*/epidemiology
Granulomatous Disease, Chronic*/complications
Granulomatous Disease, Chronic*/therapy
Hematopoietic Stem Cell Transplantation*/adverse effects
Anti-Bacterial Agents/therapeutic use ; Humans ; Transplantation Conditioning/adverse effects
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 6 6.

Tytuł :: Prospective external validation of an updated algorithm to quantify risk of febrile neutropenia in cancer patients after a cycle of chemotherapy.
Autorzy :: Bozcuk H; Department of Medical Oncology, Medical Park Hospital, Lara, Antalya, Turkey. .
Coşkun HŞ; Department of Medical Oncology, Akdeniz University Medical Faculty, Antalya, Turkey.
İlhan Y; Department of Medical Oncology, Akdeniz University Medical Faculty, Antalya, Turkey.
Göksu SS; Department of Medical Oncology, Akdeniz University Medical Faculty, Antalya, Turkey.
Yıldız M; Department of Medical Oncology, SBU Antalya SUAM, Antalya, Turkey.
Bayram S; Department of Medical Oncology, SBU Antalya SUAM, Antalya, Turkey.
Yerlikaya T; Department of Medical Oncology, SBU Antalya SUAM, Antalya, Turkey.
Koçer M; Department of Medical Oncology, SBU Antalya SUAM, Antalya, Turkey.
Artaç M; Department of Medical Oncology, Necmettin Erbakan University Meram Medical Faculty, Konya, Turkey.
Uğraklı M; Department of Medical Oncology, Necmettin Erbakan University Meram Medical Faculty, Konya, Turkey.
Ouisupov A; Department of Medical Oncology, Medical Park Hospital, Lara, Antalya, Turkey.
Aydeniz A; Department of Medical Oncology, Medical Park Hospital, Lara, Antalya, Turkey.
Şahin D; Department of Medical Oncology, Medical Park Hospital, Lara, Antalya, Turkey.
Yalçın G; Department of Medical Oncology, Medical Park Hospital, Lara, Antalya, Turkey.
Saatçi M; Department of Medical Oncology, Medical Park Hospital, Lara, Antalya, Turkey.
Mutlu H; Department of Medical Oncology, Medical Park Hospital, Lara, Antalya, Turkey.
Yıldırım M; Department of Medical Oncology, Sanko University, Gaziantep, Turkey.; Pokaż więcej
Źródło :: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2022 Mar; Vol. 30 (3), pp. 2621-2629. Date of Electronic Publication: 2021 Nov 23.
Typ publikacji :: Journal Article
MeSH Terms :: Febrile Neutropenia*/chemically induced
Febrile Neutropenia*/epidemiology
Neoplasms*/drug therapy
Algorithms ; Antineoplastic Combined Chemotherapy Protocols ; Granulocyte Colony-Stimulating Factor/therapeutic use ; Humans ; Prospective Studies
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 7 7.

Tytuł :: Sequencing for Infection Diagnostics: Is It Time to embrace the Next Generation?
Autorzy :: Vijayvargiya P; Division of Infectious Diseases, Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi, USA.
Thoendel MJ; Division of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.; Pokaż więcej
Źródło :: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2022 May 03; Vol. 74 (9), pp. 1669-1670.
Typ publikacji :: Editorial; Comment
MeSH Terms :: Cell-Free Nucleic Acids*
Febrile Neutropenia*
High-Throughput Nucleotide Sequencing ; Humans ; Immunocompromised Host
: Opinia redakcyjna

Szczegóły

Skocz do pozycji: 8 8.

Tytuł :: [G-CSF for prophylaxis of neutropenia and febrile neutropenia, anemia in cancer : Guidelines on supportive treatment part 1].
Autorzy :: Link H; Finkenhain 8, 67661, Kaiserslautern, Deutschland. .; Pokaż więcej
Transliterated Title :: G-CSF zur Prophylaxe der Neutropenie und der febrilen Neutropenie, Anämie bei Krebserkrankung : Supportivtherapieleitlinien, Teil 1.
Źródło :: Der Urologe. Ausg. A [Urologe A] 2022 May; Vol. 61 (5), pp. 537-551. Date of Electronic Publication: 2022 Apr 27.
Typ publikacji :: Journal Article
MeSH Terms :: Anemia*/complications
Anemia*/prevention & control
Febrile Neutropenia*/chemically induced
Febrile Neutropenia*/prevention & control
Neoplasms*/complications
Neoplasms*/drug therapy
Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Fever/drug therapy ; Fever/etiology ; Fever/prevention & control ; Granulocyte Colony-Stimulating Factor/therapeutic use ; Humans
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: Risk of febrile neutropenia in very elderly patients aged ≥80 years receiving their first cycle of R-CHOP regimen: a nationwide real-world study in Japan.
Autorzy :: Matsuda K; Department of Haematology and Oncology, Graduate School of Medicine, Tokyo, Japan.
Jo T; Department of Health Services Research, Graduate School of Medicine, Tokyo, Japan.
Shimura A; Department of Haematology and Oncology, Graduate School of Medicine, Tokyo, Japan.
Honda A; Department of Haematology and Oncology, Graduate School of Medicine, Tokyo, Japan.
Taoka K; Department of Haematology and Oncology, Graduate School of Medicine, Tokyo, Japan.
Masamoto Y; Department of Haematology and Oncology, Graduate School of Medicine, Tokyo, Japan.
Matsui H; Department of Clinical Epidemiology and Health Economics, School of Public Health, Tokyo, Japan.
Fushimi K; Department of Health Policy and Informatics, Tokyo Medical and Dental University Graduate School of Medicine, Tokyo, Japan.
Yasunaga H; Department of Clinical Epidemiology and Health Economics, School of Public Health, Tokyo, Japan.
Kurokawa M; Department of Haematology and Oncology, Graduate School of Medicine, Tokyo, Japan.; Department of Cell Therapy and Transplantation Medicine, The University of Tokyo Hospital, Tokyo, Japan.; Pokaż więcej
Źródło :: British journal of haematology [Br J Haematol] 2022 May; Vol. 197 (3), pp. e37-e41. Date of Electronic Publication: 2022 Jan 03.
Typ publikacji :: Letter
MeSH Terms :: Antineoplastic Combined Chemotherapy Protocols*/adverse effects
Febrile Neutropenia*/chemically induced
Aged ; Cyclophosphamide/adverse effects ; Doxorubicin/adverse effects ; Granulocyte Colony-Stimulating Factor/adverse effects ; Humans ; Japan/epidemiology ; Prednisolone ; Prednisone/adverse effects ; Rituximab/adverse effects ; Vincristine/adverse effects
SCR Protocol :: VAP-cyclo protocol
: Opinia redakcyjna

Szczegóły

Skocz do pozycji: 10 10.

Tytuł :: Chest CT Has Higher Yield for Infection than CT Sinus in Febrile Neutropenic Patients.
Autorzy :: Choi WK; Johns Hopkins Hospital: Johns Hopkins Medicine, 600 N. Wolfe Street, Phipps B-100, Baltimore, MD.
D'Sa A; Johns Hopkins Hospital: Johns Hopkins Medicine, 600 N. Wolfe Street, Phipps B-100, Baltimore, MD.
Holman JN; Johns Hopkins Hospital: Johns Hopkins Medicine, 600 N. Wolfe Street, Phipps B-100, Baltimore, MD.
Javed S; Johns Hopkins Hospital: Johns Hopkins Medicine, 600 N. Wolfe Street, Phipps B-100, Baltimore, MD.
Thompson S; Johns Hopkins Hospital: Johns Hopkins Medicine, 600 N. Wolfe Street, Phipps B-100, Baltimore, MD.
Nadgir RN; Johns Hopkins Hospital: Johns Hopkins Medicine, 600 N. Wolfe Street, Phipps B-100, Baltimore, MD.. Electronic address: .; Pokaż więcej
Źródło :: Current problems in diagnostic radiology [Curr Probl Diagn Radiol] 2022 May-Jun; Vol. 51 (3), pp. 340-343. Date of Electronic Publication: 2021 Jul 03.
Typ publikacji :: Journal Article
MeSH Terms :: Febrile Neutropenia*/complications
Febrile Neutropenia*/diagnostic imaging
Neoplasms*
Fever/diagnostic imaging ; Fever/etiology ; Humans ; Retrospective Studies ; Tomography, X-Ray Computed/methods
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 11 11.

Tytuł :: Managing febrile neutropenia in the UK in 2020.
Autorzy :: Guram S; Department of Paediatric Haematology and Oncology, University College London Hospitals NHS Foundation Trust, London, UK .
Vedi A; Department of Paediatric Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, Cambridgeshire, UK.; Pokaż więcej
Źródło :: Archives of disease in childhood. Education and practice edition [Arch Dis Child Educ Pract Ed] 2022 Apr; Vol. 107 (2), pp. 127-130. Date of Electronic Publication: 2021 Jun 03.
Typ publikacji :: Journal Article
MeSH Terms :: Febrile Neutropenia*/diagnosis
Febrile Neutropenia*/drug therapy
Neoplasms*
Anti-Bacterial Agents/therapeutic use ; Humans ; United Kingdom
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 12 12.

Tytuł :: Antimicrobial stewardship in high-risk febrile neutropenia patients.
Autorzy :: Contejean A; Faculté de Médecine, Université de Paris, 75006, Paris, France. .; Service d'hématologie, AP-HP, APHP.CUP, Hôpital Cochin, 27 rue du Faubourg Saint-Jacques, 75014, Paris, France. .; Équipe Mobile d'Infectiologie, AP-HP, APHP.CUP, Hôpital Cochin, 75014, Paris, France. .
Abbara S; UVSQ, Inserm, CESP, Anti-infective Evasion and Pharmacoepidemiology Team, Université Paris-Saclay, 78180, Montigny-le-Bretonneux, France.; Institut Pasteur, Epidemiology and Modelling of Antibiotic Evasion (EMAE), 75015, Paris, France.
Chentouh R; Équipe Mobile d'Infectiologie, AP-HP, APHP.CUP, Hôpital Cochin, 75014, Paris, France.
Alviset S; Équipe Mobile d'Infectiologie, AP-HP, APHP.CUP, Hôpital Cochin, 75014, Paris, France.
Grignano E; Service d'hématologie, AP-HP, APHP.CUP, Hôpital Cochin, 27 rue du Faubourg Saint-Jacques, 75014, Paris, France.
Gastli N; Laboratoire de bactériologie, AP-HP, APHP.CUP, Hôpital Cochin, 75014, Paris, France.
Casetta A; Equipe opérationnelle d'hygiène hospitalière, AP-HP, Hôpital Cochin, 75014, Paris, France.
Willems L; Service d'hématologie, AP-HP, APHP.CUP, Hôpital Cochin, 27 rue du Faubourg Saint-Jacques, 75014, Paris, France.
Canouï E; Équipe Mobile d'Infectiologie, AP-HP, APHP.CUP, Hôpital Cochin, 75014, Paris, France.
Charlier C; Faculté de Médecine, Université de Paris, 75006, Paris, France.; Équipe Mobile d'Infectiologie, AP-HP, APHP.CUP, Hôpital Cochin, 75014, Paris, France.; Institut Pasteur, Biology of Infection Unit, INSERM U1117, French National Reference Center and WHO Collaborating Center Listeria, Paris, France.
Pène F; Faculté de Médecine, Université de Paris, 75006, Paris, France.; Service de médecine intensive réanimation, AP-HP, APHP.CUP, Hôpital Cochin, 75014, Paris, France.
Charpentier J; Service de médecine intensive réanimation, AP-HP, APHP.CUP, Hôpital Cochin, 75014, Paris, France.
Reboul-Marty J; Département d'information médicale, AP-HP, APHP.CUP, Hôpital Cochin, 75014, Paris, France.
Batista R; Pharmacie hospitalière, AP-HP, APHP.CUP, Hôpital Cochin, 75014, Paris, France.
Bouscary D; Faculté de Médecine, Université de Paris, 75006, Paris, France.; Service d'hématologie, AP-HP, APHP.CUP, Hôpital Cochin, 27 rue du Faubourg Saint-Jacques, 75014, Paris, France.
Kernéis S; Équipe Mobile d'Infectiologie, AP-HP, APHP.CUP, Hôpital Cochin, 75014, Paris, France.; Institut Pasteur, Epidemiology and Modelling of Antibiotic Evasion (EMAE), 75015, Paris, France.; INSERM, IAME, Université de Paris, 75006, Paris, France.; Pokaż więcej
Źródło :: Antimicrobial resistance and infection control [Antimicrob Resist Infect Control] 2022 Mar 26; Vol. 11 (1), pp. 52. Date of Electronic Publication: 2022 Mar 26.
Typ publikacji :: Journal Article; Observational Study
MeSH Terms :: Antimicrobial Stewardship*/methods
Febrile Neutropenia*/drug therapy
Anti-Bacterial Agents/therapeutic use ; Carbapenems ; Humans ; Middle Aged ; Retrospective Studies
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 13 13.

Tytuł :: Pediatric Invasive Fungal Risk Score in Cancer and Hematopoietic Stem Cell Transplantation Patients With Febrile Neutropenia.
Autorzy :: Alali M; Departments of Pediatrics.
Giurcanu M; Center for Health and the Social Sciences, University of Chicago, Chicago, IL.
Elmuti L; Department of Pediatrics, University of Chicago Medicine.
Kumar M; Medicine, Division of Infectious Diseases.; Pokaż więcej
Źródło :: Journal of pediatric hematology/oncology [J Pediatr Hematol Oncol] 2022 Mar 01; Vol. 44 (2), pp. e334-e342.
Typ publikacji :: Journal Article
MeSH Terms :: Febrile Neutropenia*/drug therapy
Febrile Neutropenia*/etiology
Hematopoietic Stem Cell Transplantation*/adverse effects
Neoplasms*/drug therapy
Neoplasms*/therapy
Antifungal Agents/therapeutic use ; Child ; Humans ; Retrospective Studies ; Risk Factors
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 14 14.

Tytuł :: Effect of early granulocyte-colony-stimulating factor administration in the prevention of febrile neutropenia and impact on toxicity and efficacy of anti-CD19 CAR-T in patients with relapsed/refractory B-cell lymphoma.
Autorzy :: Liévin R; APHP, Hôpital Saint-Louis, Service Hémato-Oncologie, Paris, France.; DMU-DHI, Université de Paris - Paris Diderot, Paris, France.
Di Blasi R; APHP, Hôpital Saint-Louis, Service Hémato-Oncologie, Paris, France.; DMU-DHI, Université de Paris - Paris Diderot, Paris, France.
Morin F; APHP, Hôpital Saint-Louis, Laboratoire d'immunologie, Pari - Université de Paris, Paris, France.
Galli E; Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore, Roma, Italy.
Allain V; APHP, Hôpital Saint-Louis, Laboratoire d'immunologie, Pari - Université de Paris, Paris, France.
De Jorna R; APHP, Hôpital Saint-Louis, Service de Pharmacie, Paris, France.
Vercellino L; APHP, Hôpital Saint-Louis, Service de médecine nucléaire, Paris, France.
Parquet N; APHP, Hôpital Saint-Louis, Aphérèse, Paris, France.
Mebarki M; APHP, Hôpital Saint-Louis, Thérapie cellulaire, Paris, France.
Larghero J; APHP, Hôpital Saint-Louis, Thérapie cellulaire, Paris, France.
de Kerviler E; APHP, Hôpital Saint-Louis, Service de radiologie, Paris, France.
Madelaine I; APHP, Hôpital Saint-Louis, Service de Pharmacie, Paris, France.
Caillat-Zucman S; APHP, Hôpital Saint-Louis, Laboratoire d'immunologie, Pari - Université de Paris, Paris, France.
Chevret S; APHP, Hôpital Saint-Louis, Biostatistiques, France - Université de Paris - Paris Diderot, Paris, France.
Thieblemont C; APHP, Hôpital Saint-Louis, Service Hémato-Oncologie, Paris, France. .; DMU-DHI, Université de Paris - Paris Diderot, Paris, France. .; Pokaż więcej
Źródło :: Bone marrow transplantation [Bone Marrow Transplant] 2022 Mar; Vol. 57 (3), pp. 431-439. Date of Electronic Publication: 2022 Jan 30.
Typ publikacji :: Journal Article
MeSH Terms :: Febrile Neutropenia*/etiology
Febrile Neutropenia*/prevention & control
Lymphoma, Large B-Cell, Diffuse*/drug therapy
Receptors, Chimeric Antigen*
Antigens, CD19 ; Granulocyte Colony-Stimulating Factor/therapeutic use ; Granulocytes ; Humans ; Immunotherapy, Adoptive/adverse effects
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 15 15.

Tytuł :: A prediction model for bacteremia and transfer to intensive care in pediatric and adolescent cancer patients with febrile neutropenia.
Autorzy :: Alali M; Department of Pediatrics, Division of Infectious Diseases, University of Chicago Medicine, Chicago, IL, USA. .
Mayampurath A; Department of Pediatrics, The University of Chicago, Chicago, IL, USA.; Center for Research Informatics, The University of Chicago, Chicago, IL, USA.
Dai Y; Center for Research Informatics, The University of Chicago, Chicago, IL, USA.
Bartlett AH; Department of Pediatrics, Division of Infectious Diseases, University of Chicago Medicine, Chicago, IL, USA.; Pokaż więcej
Źródło :: Scientific reports [Sci Rep] 2022 May 06; Vol. 12 (1), pp. 7429. Date of Electronic Publication: 2022 May 06.
Typ publikacji :: Journal Article; Observational Study
MeSH Terms :: Bacteremia*/diagnosis
Febrile Neutropenia*/epidemiology
Hypotension*/complications
Neoplasms*/complications
Neoplasms*/therapy
Sepsis*/complications
Adolescent ; Child ; Critical Care ; Fever/complications ; Humans ; Logistic Models ; Retrospective Studies
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 16 16.

Tytuł :: Clinical Utility of Total Oxidative Stress and Total Antioxidant Capacity in Childhood Febrile Neutropenia.
Autorzy :: Kara B; Departments of Pediatric Hematology and Oncology.
Akyurek F; Biochemistry.
Akbas H; Department of Pediatric Hematology and Oncology, Saglik Bilimleri University, Hamidiye Faculty of Medicine, Konya Education and Research Hospital, Konya, Turkey.
Ertan K; Pediatrics, Selcuk University, Faculty of Medicine.
Vatansev H; Biochemistry.
Koksal Y; Departments of Pediatric Hematology and Oncology.; Pokaż więcej
Źródło :: Journal of pediatric hematology/oncology [J Pediatr Hematol Oncol] 2022 May 01; Vol. 44 (4), pp. 142-146. Date of Electronic Publication: 2021 Aug 13.
Typ publikacji :: Journal Article
MeSH Terms :: Antioxidants*/metabolism
Febrile Neutropenia*/drug therapy
Anti-Bacterial Agents/therapeutic use ; Child ; Humans ; Oxidants ; Oxidation-Reduction ; Oxidative Stress
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 17 17.

Tytuł :: Infectious complications of targeted drugs and biotherapies in acute leukemia. Clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN).
Autorzy :: Maschmeyer G; Certified Cancer Center, Klinikum Ernst von Bergmann, Charlottenstrasse 72, D-14467, Potsdam, Germany. .
Bullinger L; Department of Hematology, Oncology and Tumor Immunology, Campus Virchow, Charité - Universitätsmedizin Berlin, German Cancer Consortium (DKTK), Partner Site Berlin, Berlin, Germany.
Garcia-Vidal C; Infectious Diseases Department, Hospital Clinic-IDIBAPS, Villarroel 170, BCN 08036, Barcelona, Spain.
Herbrecht R; Department of Hematology, Institut de Cancérologie Strasbourg.Europe (ICANS) and Université de Strasbourg, Inserm, UMR-S1113/IRFAC, Strasbourg, France.
Maertens J; Department of Microbiology, Immunology, and Transplantation, KULeuven, Leuven and Department of Hematology, UZLEUVEN, Leuven, Belgium.
Menna P; Department of Sciences and Technologies for Humans and the Environment, University Campus Bio-Medico of Rome, University Hospital Foundation Campus Bio-Medico of Rome, Rome, Italy.
Pagano L; Hematology Division, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli - IRCCS and Università Cattolica del Sacro Cuore, Rome, Italy.
Thiebaut-Bertrand A; Department of Hematology, Grenoble University Hospital, Grenoble, France.
Calandra T; Infectious Diseases Service, Department of Medicine, Lausanne University Hospital, University of Lausanne, CH-1011, Lausanne, Switzerland.; Pokaż więcej
Źródło :: Leukemia [Leukemia] 2022 May; Vol. 36 (5), pp. 1215-1226. Date of Electronic Publication: 2022 Apr 02.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Biological Therapy*/adverse effects
Febrile Neutropenia*/chemically induced
Infections*/chemically induced
Leukemia, Myeloid, Acute*/complications
Leukemia, Myeloid, Acute*/drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/complications
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Antibodies, Monoclonal/adverse effects ; Humans ; Immunocompromised Host ; Practice Guidelines as Topic
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 18 18.

Tytuł :: COVID 19 and febrile neutropenia: Case report and systematic review.
Autorzy :: Kaya T; Department of Internal Medicine, VM Medicalpark Samsun Hospital, Samsun, Turkey. Electronic address: .
Dilek A; Intensive Care Unit, VM Medicalpark Samsun Hospital, Samsun, Turkey; Istinye University, Faculty of Medicine, Istanbul, Turkey. Electronic address: .
Ozaras R; Department of Infectious Diseases, Medilife Health Group, Istanbul, Turkey. Electronic address: .
Balcik OS; Department of Hematology, VM Medicalpark Samsun Hospital, Samsun, Turkey. Electronic address: .
Leblebicioglu H; Department of Infectious Diseases, VM Medicalpark Samsun Hospital, Samsun, Turkey. Electronic address: .; Pokaż więcej
Źródło :: Travel medicine and infectious disease [Travel Med Infect Dis] 2022 May-Jun; Vol. 47, pp. 102305. Date of Electronic Publication: 2022 Mar 07.
Typ publikacji :: Case Reports; Journal Article; Review; Systematic Review
MeSH Terms :: COVID-19*
Febrile Neutropenia*/drug therapy
Hematologic Neoplasms*/complications
Hematologic Neoplasms*/drug therapy
Neoplasms*
Respiratory Distress Syndrome*/etiology
Female ; Fever/etiology ; Granulocyte Colony-Stimulating Factor/therapeutic use ; Humans ; Male
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 19 19.

Tytuł :: Comprehensive analysis of the associations between clinical factors and outcomes by machine learning, using post marketing surveillance data of cabazitaxel in patients with castration-resistant prostate cancer.
Autorzy :: Kazama H; Sanofi Specialty Care Medical Oncology, 3-20-2 Nishi-Shinjuku, Shinjuku, Tokyo, 163-1488, Japan.
Kawaguchi O; Sanofi Research and Development, 3-20-2 Nishi-Shinjuku, Shinjuku, Tokyo, 163-1488, Japan.
Seto T; Sanofi Medical Affairs, 3-20-2 Nishi-Shinjuku, Shinjuku, Tokyo, 163-1488, Japan.
Suzuki K; Department of Urology, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, Gunma, 371-8511, Japan.
Matsuyama H; Department of Urology, Yamaguchi University Graduate School of Medicine, 1-1-1 Minami-Kogushi, Ube, Yamaguchi, 755-8505, Japan.
Matsubara N; Department of Medical Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan.
Tajima Y; Sanofi Medical Affairs, 3-20-2 Nishi-Shinjuku, Shinjuku, Tokyo, 163-1488, Japan.
Fukao T; Sanofi Global Oncology, 450 Water Street, Cambridge, MA, 02141, USA. .; Pokaż więcej
Źródło :: BMC cancer [BMC Cancer] 2022 Apr 29; Vol. 22 (1), pp. 470. Date of Electronic Publication: 2022 Apr 29.
Typ publikacji :: Journal Article; Multicenter Study; Observational Study
MeSH Terms :: Febrile Neutropenia*
Liver Neoplasms*
Prostatic Neoplasms, Castration-Resistant*/pathology
Aged ; Humans ; Machine Learning ; Male ; Product Surveillance, Postmarketing ; Prospective Studies ; Taxoids
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 20 20.

Tytuł :: Review of Hematological and Oncological Emergencies.
Autorzy :: Barré S; Ochsner Louisiana State University Health, Shreveport (Dr Barré); Atrium Health's Carolinas Medical Center, Charlotte, North Carolina (Dr McElwee); Medical University of South Carolina, Charleston (Drs Calhoun, Maldonado, and Bell); and Department of Clinical Pharmacy and Outcome Sciences, University of South Carolina College of Pharmacy, Columbia (Dr Weant).
McElwee J
Calhoun C
Weant KA
Maldonado A
Bell CM; Pokaż więcej
Źródło :: Advanced emergency nursing journal [Adv Emerg Nurs J] 2022 Apr-Jun 01; Vol. 44 (2), pp. 84-102.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Febrile Neutropenia*/etiology
Neoplasms*/complications
Neoplasms*/therapy
Emergencies ; Humans ; Immunotherapy, Adoptive/adverse effects ; Receptors, Antigen, T-Cell ; T-Lymphocytes/pathology
: Czasopismo naukowe

Szczegóły

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Febrile neutropenia"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język